Gender gap in life expectancy: The reasons for a reduction of female advantage;Écart d'espérance de vie entre les sexes: Les raisons du recul de l'avantage féminin

Revue d'Epidemiologie et de Sante Publique

Volumn 52, Issue 4, 2004, Pages 333-352

  Mesle F ^a  

^a INSTITUT NATIONAL D'ÉTUDES DÉMOGRAPHIQUES   (France)

Author keywords

Causes of death; Differential mortality; France; Gender; Industrialised countries; Life expectancy; Male excess mortality

Indexed keywords

ARTICLE; CANCER; CANCER MORTALITY; CAUSE OF DEATH; DATA ANALYSIS; DEATH; FRANCE; HUMAN; INDUSTRIALIZATION; LIFE EXPECTANCY; LIFE TABLE; MORTALITY; PROBABILITY; RESPIRATORY TRACT DISEASE; SEX DIFFERENCE; ADOLESCENT; ADULT; AGED; CHILD; COMPARATIVE STUDY; EUROPE; FEMALE; INFANT; JAPAN; MALE; MIDDLE AGED; PRESCHOOL CHILD; SEX RATIO;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; EUROPE; FEMALE; FRANCE; HUMANS; INFANT; JAPAN; LIFE EXPECTANCY; MALE; MIDDLE AGED; MORTALITY; SEX DISTRIBUTION; SEX FACTORS;

EID: 4544222643     PISSN: 03987620     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0398-7620(04)99063-3     Document Type: Article

References (23)

1. Lopez A, Ruzicka LT. Sex differentials in mortality: trends, determinants and consequences. Canberra, Australian National University, Demography Department, 1983.
2. Waldron I. Contributions of biological and behavioural factors to changing sex differences in ischaemic heart disease mortality. In: Lopez AD, Caselli G, Valkonen T, eds. Adult mortality in developed countries: from description to explanation. Oxford: Oxford University Press, 1995: 161-78.
3. Vallin J. Social change and mortality decline: women's advantage regained or achieved? In: Federici N, Manson C, Sogner S, eds. Women's position and demographic change in the course of development. Oxford: Clarendon Press, 1993: 190-212.
4. Nathanson CA. Mortality and the position of women in developed countries. In: Lopez AD, Caselli G, Valkonen T, eds. Adult mortality in developed countries: from description to explanation. Oxford: Oxford University Press, 1995: 135-57.
5. Garros B, Bouvier MH. Excès de la surmortalité masculine en France et causes médicales de décès. Population 1978; 33: 1095-113.
6. Trovato F, Lalu NM. Contribution of cause-specific mortality to changing sex differences in life expectancy: seven nations case study. Soc Biol 2003; 45: 1-20.
7. Vallin J. Mortalité, sexe et genre. In: Caselli G, Wunsch G, Vallin J, eds. Démographie: analyse et synthèse. III- Les déterminants de la mortalité. Paris: INED, 2002: 319-50.
8. Vallin J, Meslé F. A long terme, l'écart d'espérance de vie entre hommes et femmes devrait diminuer. Population 1989; 44: 1244-51.
9. c siècles et projections pour le XXF. Paris: INED, 2001.
10. Vallin J, Meslé F. Comment suivre l'évolution de la mortalité par cause malgré les discontinuités de la statistique. Le cas de la France de 1925 à 1993. In: Pavillon G, éd. Enjeux des classifications internationales en santé. Paris: Éditions INSERM, 1998: 113-56.
11. Henry L, Blayo Y. La population de la France de 1740 à 1860. Population 1975; 30 (spécial « Démographie historique »): 71-122.
12. Andreev E, Shkolnikov V, Begun AZ. Algorithm for decomposition of differences between aggregate demographic measures and its application to life expectancies, healthy life expectancies, parity-progression ratios and total fertility rates. Demographic Research 2002; 7: 500-21.
13. c Assemblée Mondiale de la Santé. Volume 1. Genève: Organisation Mondiale de la Santé, 1977.
14. Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Mem Fund Q 1971; 49: 509-38.
15. Meslé F, Vallin J. Transition sanitaire: tendances et perspectives. Médecine Sciences 2000; 16: 1161-71.
16. Olshansky J, Ault B. The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases. Milbank Q 1986; 64: 355-91.
17. Rogers RG, Hackenberg R. Extending epidemiologic transition theory. Soc Biol 1987; 34: 234-43.
18. Frenk J, Bobadilla JL, Stern C, Frejka T, Lozano R. Elements for a theory of the health transition. Health Transition Review 1991; 1: 21-38.
19. Vallin J, Meslé F. Convergences and divergences in mortality. A new approach of health transition. Demographic Research 2004; 12: 43.
20. Meslé F. La mortalité en France: le recul se poursuit. Population 1995; 50: 743-76.
21. Meslé F, Vallin J. Mortalité en Europe: la divergence est-ouest. Population 2002; 57: 171-212.
22. Meslé F, Vallin J. Évolution et variations géographiques de la surmortalité masculine: du paradoxe français à la logique russe. Population 1998; 53: 1079-102.
23. Conti S, Farchi G, Masocco M, Minelli G, Toccaceli V, Vichi M. Gender differentials in life expectancy in Italy. Eur J Epidemiol 2003; 18: 107-12.